14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 18, 2024 Buy 93 879 Berkowitz Noah Stock Option (right to buy)
Mar 18, 2024 Buy 63 452 Berkowitz Noah Common Stock
Mar 18, 2024 Buy 0 Berkowitz Noah
Feb 29, 2024 Buy 0 Teel Randy Common Stock
Feb 29, 2024 Buy 0 Teel Randy Common Stock
Feb 29, 2024 Buy 0 Teel Randy Common Stock
Feb 29, 2024 Buy 104 605 Teel Randy Stock Option (right to buy)
Feb 29, 2024 Buy 52 400 Teel Randy Stock Option (right to buy)
Feb 29, 2024 Buy 34 161 Teel Randy Stock Option (right to buy)
Feb 29, 2024 Buy 38 350 Teel Randy Stock Option (right to buy)
Feb 29, 2024 Buy 37 000 Teel Randy Stock Option (right to buy)
Feb 29, 2024 Buy 40 000 Teel Randy Stock Option (right to buy)
Feb 29, 2024 Buy 46 945 Teel Randy Stock Option (right to buy)
Feb 23, 2024 Buy 124 450 Houston John G Common Stock
Feb 23, 2024 Sell 5 196 Houston John G Common Stock
Feb 23, 2024 Buy 184 200 Houston John G Stock Option (right to buy)
Feb 23, 2024 Sell 1 702 Cassidy Sean A Common Stock
Feb 23, 2024 Buy 39 250 Peck Ronald Common Stock
Feb 23, 2024 Sell 1 699 Peck Ronald Common Stock
Feb 23, 2024 Buy 58 100 Peck Ronald Stock Option (right to buy)
Feb 23, 2024 Buy 39 250 Taylor Ian Common Stock
Feb 23, 2024 Sell 1 701 Taylor Ian Common Stock
Feb 23, 2024 Buy 58 100 Taylor Ian Stock Option (right to buy)
Feb 23, 2024 Buy 8 750 Loomis David K Stock Option (right to buy)
Feb 23, 2024 Buy 5 750 Loomis David K Common Stock
Jan 04, 2024 Buy 8 252 Taylor Ian Common Stock
Jan 04, 2024 Sell 0 Taylor Ian Stock Option (right to buy)
Jan 04, 2024 Sell 0 Taylor Ian Stock Option (right to buy)
Aug 11, 2023 Buy 4 010 Peck Ronald Common Stock
Aug 11, 2023 Sell 1 324 Peck Ronald Common Stock
Aug 11, 2023 Sell 4 010 Peck Ronald Restricted Stock Units
Jun 15, 2023 Buy 12 787 Young John D Stock Option (right to buy)
Jun 15, 2023 Buy 4 121 Young John D Common Stock
Jun 15, 2023 Buy 12 787 Smaldone Alsup Laurie Stock Option (right to buy)
Jun 15, 2023 Buy 4 121 Smaldone Alsup Laurie Common Stock
Jun 15, 2023 Buy 12 787 Norwalk Leslie V Stock Option (right to buy)
Jun 15, 2023 Buy 4 121 Norwalk Leslie V Common Stock
Jun 15, 2023 Buy 4 121 Morrison Briggs Common Stock
Jun 15, 2023 Buy 12 787 Morrison Briggs Stock Option (right to buy)
Jun 15, 2023 Buy 4 121 Kennedy Edward Moore Jr. Common Stock
Jun 15, 2023 Buy 12 787 Kennedy Edward Moore Jr. Stock Option (right to buy)
Jun 15, 2023 Buy 12 787 Dixon Wendy L Stock Option (right to buy)
Jun 15, 2023 Buy 4 121 Dixon Wendy L Common Stock
Jun 15, 2023 Buy 12 787 Cunningham Everett Stock Option (right to buy)
Jun 15, 2023 Buy 4 121 Cunningham Everett Common Stock
Jun 15, 2023 Buy 12 787 Bain Linda Stock Option (right to buy)
Jun 15, 2023 Buy 4 121 Bain Linda Common Stock
Jun 15, 2023 Buy 24 948 Agarwal Sunil Stock Option (right to buy)
Jun 15, 2023 Buy 8 242 Agarwal Sunil Common Stock
Jun 15, 2023 Buy 0 Agarwal Sunil
Mar 01, 2023 Buy 2 685 Taylor Ian Common Stock
Mar 01, 2023 Sell 1 051 Taylor Ian Common Stock
Mar 01, 2023 Sell 2 685 Taylor Ian Restricted Stock Units
Mar 01, 2023 Buy 17 510 Houston John G Common Stock
Mar 01, 2023 Sell 5 878 Houston John G Common Stock
Mar 01, 2023 Sell 17 510 Houston John G Restricted Stock Units
Mar 01, 2023 Buy 4 791 Cassidy Sean A Common Stock
Mar 01, 2023 Sell 1 745 Cassidy Sean A Common Stock
Mar 01, 2023 Sell 4 791 Cassidy Sean A Restricted Stock Units
Feb 22, 2023 Buy 19 125 Cassidy Sean A Common Stock
Feb 22, 2023 Buy 57 450 Cassidy Sean A Stock Option (right to buy)
Feb 22, 2023 Buy 57 450 Peck Ronald Stock Option (right to buy)
Feb 22, 2023 Buy 19 125 Peck Ronald Common Stock
Feb 22, 2023 Buy 61 975 Houston John G Common Stock
Feb 22, 2023 Buy 186 250 Houston John G Stock Option (right to buy)
Feb 22, 2023 Buy 19 125 Taylor Ian Common Stock
Feb 22, 2023 Buy 57 450 Taylor Ian Stock Option (right to buy)
Dec 15, 2022 Buy 27 500 Loomis David K Stock Option (right to buy)
Dec 15, 2022 Buy 0 Loomis David K Common Stock
Dec 15, 2022 Buy 30 095 Cunningham Everett Common Stock
Dec 15, 2022 Buy 0 Cunningham Everett
Dec 15, 2022 Buy 0 Cunningham Everett
Aug 18, 2022 Buy 24 572 Young John D Stock Option (right to buy)
Aug 18, 2022 Buy 0 Young John D
Aug 12, 2022 Buy 4 010 Peck Ronald Common Stock
Aug 12, 2022 Sell 1 258 Peck Ronald Common Stock
Aug 12, 2022 Sell 4 010 Peck Ronald Restricted Stock Units
Aug 12, 2022 Buy 4 010 Peck Ronald Common Stock
Aug 12, 2022 Sell 1 258 Peck Ronald Common Stock
Jun 16, 2022 Buy 10 192 Dixon Wendy L Stock Option (right to buy)
Jun 16, 2022 Buy 10 192 Dixon Wendy L Stock Option (right to buy)
Jun 16, 2022 Buy 10 192 Shannon Timothy M Stock Option (right to buy)
Jun 16, 2022 Buy 10 192 Ratcliffe Liam Stock Option (right to buy)
Jun 16, 2022 Buy 10 192 Ratcliffe Liam Stock Option (right to buy)
Jun 16, 2022 Buy 10 192 Kennedy Edward Moore Jr. Stock Option (right to buy)
Jun 16, 2022 Buy 10 192 Kennedy Edward Moore Jr. Stock Option (right to buy)
Jun 16, 2022 Buy 10 192 Smaldone Alsup Laurie Stock Option (right to buy)
Jun 16, 2022 Buy 10 192 Bain Linda Stock Option (right to buy)
Jun 16, 2022 Buy 10 192 Margus Bradley Albert Stock Option (right to buy)
Jun 16, 2022 Buy 10 192 Margus Bradley Albert Stock Option (right to buy)
Jun 16, 2022 Buy 10 192 Morrison Briggs Stock Option (right to buy)
Jun 16, 2022 Buy 10 192 Morrison Briggs Stock Option (right to buy)
Jun 16, 2022 Buy 10 192 Norwalk Leslie V Stock Option (right to buy)
Jun 16, 2022 Buy 10 192 Norwalk Leslie V Stock Option (right to buy)
Apr 14, 2022 Buy 16 188 Morrison Briggs Common Stock
Apr 14, 2022 Sell 3 102 Morrison Briggs Common Stock
Apr 14, 2022 Sell 7 104 Morrison Briggs Common Stock
Apr 14, 2022 Sell 10 754 Morrison Briggs Common Stock
Apr 14, 2022 Sell 16 188 Morrison Briggs Stock Option (right to buy)
Apr 14, 2022 Sell 16 188 Morrison Briggs Stock Option (right to buy)
INSIDER POWER
89.779
Last 100 transactions
Buy: 1 971 549 | Sell: 109 154 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 89.779.

In total, the insiders bought 1 971 549 and sold 109 154 ARVN shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Arvinas Inc.

Arvinas. Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC); ARV... ARVN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT